Investigators analyzed IBD subtypes and their associated risks of radical prostatectomy complications among a cohort of patients with prostate cancer to fill a knowledge gap.
Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, today announced the commercial launch of ...
In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback